Amkor Technology, Inc. (AMKR) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript

Amkor Technology announced an expansion of its Arizona Phase 2 investment to $12 billion from $7 billion, accelerating its U.S. advanced semiconductor packaging footprint. Management cited demand growth and progress on strategic partnerships with TSMC and NVIDIA as key drivers. The investment supports geographic supply-chain diversification and Amkor's positioning in advanced packaging, with potentially meaningful implications for its long-term capacity and customer relationships.

Analysis

AMKR’s incremental Arizona commitment shifts the valuation debate from cyclical outsourced assembly/test exposure toward whether it can become a strategically scarce US advanced-packaging asset. The near-term equity sensitivity is not the announced capex headline but the conversion of customer partnerships into binding capacity commitments, prepayments, or take-or-pay structures; without these, free-cash-flow pressure and leverage risk will dominate before utilization ramps. TSM’s Arizona wafer output creates a local packaging bottleneck, making AMKR more relevant to US-sourced AI/HPC supply chains than offshore OSAT peers ASE Technology (ASX) and JCET.

The second-order beneficiary is NVDA only at the margin: domestic packaging redundancy reduces supply-chain interruption risk, but it does not solve leading-edge CoWoS availability, where TSM remains the binding constraint. AMKR’s opportunity is strongest in advanced test, substrate-level integration and non-leading-edge heterogeneous packages; investors should avoid assuming it captures TSMC’s highest-value packaging economics. A broader US semiconductor incentive or defense-oriented procurement regime could improve returns on the facility over 6-18 months, while a delay in customer qualification would turn fixed-cost absorption into the central risk.

Consensus may over-credit geopolitical demand before construction and qualification milestones are visible. Over the next 1-3 months, AMKR can re-rate if management discloses committed utilization, customer-funded capex, and returns above its cost of capital; absent that evidence, the stock is vulnerable to a capex-driven multiple discount even if long-term strategic logic remains intact. Falsify the constructive case if FY2027 capex rises without disclosed prepayments/volume commitments, or if management indicates Arizona ramp dilution beyond initial expectations.

Key Decisions for Investors

• Maintain or initiate a measured long AMKR position over a 6-18 month horizon only after confirming customer commitments and funding terms; target a 15-25% upside on strategic multiple expansion, with thesis risk centered on unutilized capacity and FCF dilution.
• Prefer a pair trade long AMKR / short ASX for 3-9 months if US-content requirements or TSM Arizona volume commitments accelerate. The trade isolates geographic packaging scarcity; exit if AMKR cannot demonstrate comparable advanced-package yields, qualification progress, or customer-backed utilization.
• Do not add NVDA solely on this development. Treat any benefit as supply-resilience optionality rather than a material earnings catalyst; NVDA’s packaging constraint remains principally TSMC’s leading-edge capacity and broader AI demand.
• Set an event-driven alert for AMKR’s next earnings call: buy incremental exposure only if management quantifies Arizona customer allocations, prepayments, expected utilization, and return profile. A capex increase without those disclosures is a reason to reduce exposure rather than chase momentum.